Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-152-2 | CAS number: 78-87-5
Neurotoxicity
Administrative data
Description of key information
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 200 mg/kg bw/day
Additional information
The neurological consequences of repeated oral exposure to DCP have been investigated in F344 rats (n = 15/sex/group) given 0 (corn oil), 20, 65 or 200 mg/kg bw/day for 13 weeks by gavage. The study followed U.S. E.P.A. guidelines and was conducted to the standards of GLP. Prior to treatment, and at monthly intervals during the study, all animals were assessed for a number of endpoints including functional observational battery, hindlimb grip strength, and motor activity. After a 13-week treatment, 4 rats/sex/dose were randomly selected for terminal examination (including histopathological examination of brain, spinal cord and nerve) while the remainder were retained (no further treatment) for a 9 week recovery period. Transient clinical signs (lacrimation, blinking, and decreased spontaneous motor activity) were reported on days 3-4 of treatment, and body weight was slightly decreased at week 13 in both sexes. There were no effects attributable to DCP in the functional observational battery, grip strength, or motor activity. Results from the gross and microscopic examination of the brain and nervous system revealed no treatment-related lesions. Overall, apart from a minor effect on body weight (NOAEL males = 20 mg/kg bw/day; NOAEL females 65 mg/kg bw/day), no adverse structural or functional neurological consequences were apparent in rats following 13 weeks gavage administration of DCP at doses up to 200 mg/kg bw/day.
Justification for classification or non-classification
No effectrs in a 13 week study up to the highest dose level.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
